Neurocrine Biosciences stock sentiment

NBIX
NASDAQDrug Manufacturers - Specialty & GenericData as of Nov 10, 2026

Over the past week, Neurocrine Biosciences (NBIX) pulled in 14 mentions across Reddit, X and News. The read is an Adanos Buy. The crowd average is 36% bullish. Wall Street is more constructive, with 25 of 29 analysts rating NBIX a buy. NBIX reads clearly more bullish than usual this week. Its Adanos Score is 70.7 out of 100, a Buy.

Adanos signal

Buy70.7

Confidence low · Sources 1 / 4

Avg buzz

36.3out of 100

31.8 to 66.9 over the last 6 sessions

Crowd average

36%

5 of 6 sessions leaned bullish

Mentions, last 7 days

14

  • News14↓
  • X0→
  • YouTubeComing soon

Neurocrine Biosciences (NBIX) buzz score vs. EOD price

BuzzEOD closeVolumeBullish, neutral, bearish
$169.14+25.2% over 21 sessions
Oct 13Nov 10

Prices run to Nov 10, 2026. The sentiment can be newer. Neurocrine Biosciences (NBIX) buzz ended the 30 days at 41.0 while the price drifted up 25.2% across the period. Average daily volume over the 21 sessions is 1.5M shares. Updated Nov 11, 2026. Over the last 7 sessions, NBIX gained 16.4%. Buzz in those sessions averaged 43.6 and was variable, swinging between 31.8 and 66.9. Recent volume is running above the 30-day average. Daily crowd sentiment leaned bullish on 8 of the 17 days with directional mentions.

Neurocrine Biosciences (NBIX) at a glance

Adanos signal
Buy
Analyst consensus
Strong Buy (25 / 4 / 0)
Crowd average (7d)
36%
Avg price target
$207.50
Most bullish source
News, 36%
Mentions (7d)
14
Market cap
$16.17B
P/E · Forward P/E
24.7 · 16.9
EPS · Beta
$6.48 · 0.3
Revenue (TTM)
$3.7B · 19% margin
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
21-session range
$135.13 to $169.14
Avg daily volume
1.5M

Why NBIX reads Buy

Score parts, 7 days

NBIX scores 70.7 out of 100. That reaches the 70 a Buy needs. X is not counted this week. It has no bullish and bearish shares. Confidence is low. 14 mentions and trades is under the 100 that medium needs.

News+10.3

Clearly above usual. 36% bullish minus 0% bearish is a lean of +36. The usual lean is +11. Counted at 41.2%, that is +10.3 against usual, at weight 1.18.

Weighted lean
+10.3
Agreement 1.00
× 1.00
1 source
× 0.90
Buzz 36
× 0.90
Total
+8.3
Adanos Score, 0 to 100
70.7

Usual levels as of Oct 28, 2026. The scale is 50 + 50 × tanh(total ÷ 18.9), so a total of +8 lands at 70 and −8 at 30. Figures are rounded. The score uses the exact values.

Wall Street vs the crowd on NBIX

Here is how Wall Street and the crowd line up on Neurocrine Biosciences this week.

Analyst ratings

Strong Buy29 analysts · 86% buy share
25 Buy4 Hold0 Sell

+22.7% from the last close to the average target

Last close $169.14Avg target $207.50

29 analysts cover NBIX with a Strong Buy consensus. 25 rate it a buy and 0 a sell. Their average 12-month target is $207.50.

Who is bullish on NBIX

Crowd average 36%
Wall St 50 pts 86%
News 36%
0%50%100%
Above its usual lean

Analysts sit 50 points above the crowd average of 36%.

How each source saw NBIX this week

Buzz, bullish share, mentions and trades cover the last 7 days. Subreddit, publisher and trader counts, the top post and the top story cover 30 days.

XStableX API
Buzz
-
Bullish
-
Mentions
0

0 tweets

@funfactonstocksTop post, 30 days
“$WULF $CORZ $CIFR $MARA $CRWV $NBIX $ANT”
Neutral 0.05
NewsFallingNews API
Buzz
36.3
Bullish
36%
Mentions
14
Bullish 36%Neutral 64%Bearish 0%

16 publishers in 30 days · 7-day sentiment +0.4

PR NewswireTop story, 30 days
“SAN DIEGO, Nov. 10, 2026 / / - Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that its executives will participate at the 2026…” MarketBeat and Stocktitan lead the coverage.
Neutral 0

NBIX in its industry

Drug Manufacturers - Specialty & Generic · 16 most discussed, 7 days
Closest readings to NBIXTile size: mentions

Explore nearby tickers

  1. NAVINavient CorpHold20% bullish
  2. NAVNNavan Inc - Class AHold31% bullish
  3. NBNioCorp Developments Ltd.Hold13% bullish
  4. NBISNebius Group N.V. - Class ABuy34% bullish
  5. NBIXNeurocrine BiosciencesBuy36% bullish
  6. NCLHNorwegian Cruise Line Holdings LtdHold15% bullish
  7. NCRANocera IncHold100% bullish
  8. NDLSNoodles & Company - Class AHold25% bullish
  9. NDRAENDRA Life Sciences IncHold

Neurocrine Biosciences (NBIX) stock sentiment FAQ

Is Neurocrine Biosciences (NBIX) a buy or sell right now?

Based on aggregated sentiment from News, Neurocrine Biosciences (NBIX) carries an Adanos buy signal with an Adanos Score of 70.7 out of 100. Confidence is low. 14 mentions and trades is under the 100 that medium needs. The crowd average reads 36% bullish across 1 active source. Over the last 7 days those sources carry 14 mentions. This is a sentiment-based reading, not financial advice.

Is Neurocrine Biosciences (NBIX) bullish or bearish right now?

Neurocrine Biosciences (NBIX) reads clearly more bullish than usual this week, with an Adanos Score of 70.7 out of 100. In plain shares the crowd average is 36% bullish across 1 tracked source over the last 7 days. On Wall Street, 25 of 29 analysts rate NBIX a buy.

What do analysts say about Neurocrine Biosciences (NBIX)?

Of the 29 analysts covering Neurocrine Biosciences (NBIX), 25 rate it a buy, 4 a hold and 0 a sell, for a strong buy consensus. The average price target is $207.50. That puts Wall Street ahead of the crowd average of 36% bullish.

What is the sentiment on NBIX stock?

Neurocrine Biosciences (NBIX)'s crowd average is 36% bullish. News reads 36% bullish. News reads clearly more bullish than usual. Confidence is low. 14 mentions and trades is under the 100 that medium needs.

Why does NBIX carry a buy signal right now?

NBIX scores 70.7 out of 100. That reaches the 70 a Buy needs. X is not counted this week. It has no bullish and bearish shares. Confidence is low. 14 mentions and trades is under the 100 that medium needs. News reads clearly more bullish than usual.

What is driving Neurocrine Biosciences (NBIX) sentiment right now?

News is the dominant discussion channel with 14 mentions (100% of all mentions). The crowd average is 36% bullish. News reads clearly more bullish than usual.

What does the Adanos buy signal mean for Neurocrine Biosciences (NBIX)?

Each source's lean is its bullish share minus its bearish share. The Adanos Score compares it with that source's usual lean and weighs busier sources more. It runs from 0 to 100 with 50 as neutral. 70 or more reads Buy and 30 or less reads Sell. Everything between is Hold. Under 10 mentions and trades a stock stays at Hold. NBIX scores 70.7 out of 100 this week, so it reads Buy. It is a research shortcut, not financial advice.

How fresh is this NBIX sentiment data?

Adanos rebuilds the NBIX page once a week. When someone opens it while its sentiment is more than 24 hours old, a background update fetches fresh Reddit, X, News and Polymarket readings and the latest daily prices. The next visit shows them. Company facts and analyst ratings update with the weekly rebuild. The sentiment figures cover the last 7 days.

Explore more stocks

Build on this data

  • Finance Sentiment CLIQuery sentiment for NBIX and 50,000+ tickers from your terminal. Filter by source, date range and minimum buzz.View CLI
  • Website widgetsEmbed live NBIX sentiment on your own site with drop-in web components.View widgets